P&K Skin Research Center Co. Ltd (347740) — Capital Reinvestment Ratio

Latest as of September 2025: 0.17x

P&K Skin Research Center Co. Ltd (347740) has a Capital Reinvestment Ratio of 0.17x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩1.70 Billion) in capital expenditures (₩281.11 Million). See cash generation quality of P&K Skin Research Center Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.17x
Capex / Operating Cash Flow

Operating Cash Flow

₩1.70 Billion
KRW

Capital Expenditures

₩281.11 Million
KRW

Data as of

Sep 2025
Most recent filing

P&K Skin Research Center Co. Ltd Capital Reinvestment Ratio (2018–2024)

This chart tracks P&K Skin Research Center Co. Ltd's Capital Reinvestment Ratio across 7 annual periods.

Annual Capital Reinvestment Ratio for P&K Skin Research Center Co. Ltd (2018–2024)

Year-by-year Capital Reinvestment Ratio for P&K Skin Research Center Co. Ltd from 2018 to 2024. For live market cap and broader valuation context, see P&K Skin Research Center Co. Ltd market cap and net worth.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2024 0.07x ₩9.03 Billion ₩622.12 Million ▼ -75.5%
2023 0.28x ₩5.55 Billion ₩1.56 Billion ▲ +55.6%
2022 0.18x ₩7.51 Billion ₩1.36 Billion ▼ -50.5%
2021 0.37x ₩7.70 Billion ₩2.81 Billion ▲ +200.0%
2020 0.12x ₩8.67 Billion ₩1.05 Billion ▲ +46.0%
2019 0.08x ₩6.49 Billion ₩541.19 Million ▼ -45.8%
2018 0.15x ₩4.26 Billion ₩655.80 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow